Intravascular Ultrasound (IVUS) Devices Market Growth and Analysis by 2028

Intravascular Ultrasound (IVUS) Devices Market Forecast to 2028 - Analysis By Type (Equipment and Accessories); Modality (Virtual Histology IVUS, iMap IVUS, and Integrated Backscatter IVUS); End User (Hospitals and Clinics, Diagnostic Centers, and Academic and Research Institutes)

Historic Data: 2019-2020 | Base Year: 2021 | Forecast Period: 2022-2028
  • Status : Published
  • Report Code : TIPRE00009788
  • Category : Life Sciences
  • No. of Pages : 205
  • Available Report Formats : pdf-format excel-format
  • Last update date : June 18, 2024
Intravascular Ultrasound (IVUS) Devices Market Growth and Analysis by 2028
Report Date: June 18, 2024   |   Report Code: TIPRE00009788 Email: sales@theinsightpartners.com

2021 Market Size

US$ 608.97 Mn

Base year value

2028 Forecast

US$ 1,012.37 Mn

Projected by 2028

CAGR 2022-2028

7.5 %

Growth rate

Addressable Market

US$ 5,752.56 Mn

(2022-2028)

[Research Report] The intravascular ultrasound (IVUS) devices market is expected to grow from US$ 608.97 million in 2021 to US$ 1,012.37 million by 2028; it is estimated to grow at a CAGR of 7.5% from 2021 to 2028.

The report offers insights and in-depth analysis of the intravascular ultrasound (IVUS) devices market concerning various parameters such as market trends and opportunities, market dynamics, and competitive landscape analysis of leading market players across North America, Europe, Asia-Pacific, South and Central America, and Middle East & Africa. It also includes the impact analysis of the COVID-19 pandemic across the regions.

Market Assessment and Insights

  • North America dominated the market with 36.3% share in 2021.
  • Asia Pacific is poised to grow at a CAGR of 8% over the forecast period.
  • United States market is projected to grow at a CAGR of 7.8% over the forecast period.
  • By Modality, the Virtual Histology IVUS segment accounted for the largest market share of 40.6% in 2021.
  • By Type, the Accessories segment is anticipated to witness the fastest growth, registering a CAGR of 7.7% over the forecast period
  • By Equipment, the Catheters segment accounted for the largest market share of 51.9% in 2021.
  • By End User, the Diagnostic Centers segment is anticipated to witness the fastest growth, registering a CAGR of 7.9% over the forecast period
  • The report profiles key industry players such as Siemens AG, Abbott Laboratories, Terumo Corp, Boston Scientific Corp, Koninklijke Philips NV, GE HealthCare Technologies Inc, Canon Medical Systems Corp, Infraredx, Inc., Conavi Medical Inc., ACIST Medical System, while also analyzing key developments in novel ideas, disruptive products, and innovative services that could reshape the future market and reveal emerging themes across the industry.

Source: The Insight Partners' analysis based on proprietary research, government publications, company annual reports, investor presentations, industry databases, and expert interviews.

● REPORT CUSTOMIZATION

Tailor This Report To Align With Your Specific Business Requirements

This report can be customized to align precisely with your business objectives, scope, and target markets. Customization options include tailored segmentation, geography, competitive analysis, and strategic insights to support informed decision-making.

Customize This Report →

WHAT YOU CAN ADJUST

  • Segmentations
  • Geography
  • Competitive Analysis
  • Language Preferences

Intravascular Ultrasound (IVUS) Devices Market: Strategic Insights

intravascular-ultrasound-devices-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Market Insights

Rise in Cardiovascular Disorders

CVDs continue to be the most significant cause of morbidity and mortality worldwide. An unhealthy diet is the most crucial lifestyle factor that leads to CVDs. According to the WHO, CVDs are one of the causes of death accounting for nearly 17.9 million deaths worldwide in 2019.

A few of the primary risk factors of CVDs include family history, ethnicity, age, and other risk factors: tobacco consumption, hypertension, obesity, high cholesterol, physical inactivity, diabetes, unhealthy diets, and alcohol consumption. The majority of CVDs can be prevented through pre-monitoring and pre-diagnosis using intravascular ultrasound devices. Therefore, the growing number of CVDs is propelling the demand for intravascular ultrasound devices.

Due to the COVID-19 pandemic, the demand for intravascular ultrasound (IVUS) devices has increased. The intravascular ultrasound (IVUS) devices market in Asia Pacific is likely to expand at a rapid pace in the near future. This expansion can be majorly attributed to the availability of trained and well-qualified technicians and rise in adoption of technologically advanced diagnostic equipment.

Modality-Based Insights

Based on modality, the intravascular ultrasound (IVUS) devices market is segmented into virtual histology IVUS, iMap IVUS, and integrated backscatter IVUS. In 2021, virtual histology IVUS segment held a larger market share. However, the iMap IVUS segment is estimated to register a higher CAGR of 8.0% during the forecast period.

Intravascular Ultrasound Devices

Intravascular Ultrasound (IVUS) Devices Market Report Scope

Report Attribute Details
Market size in 2021 US$ 608.97 Million
Market Size by 2028 US$ 1,012.37 Million
Global CAGR (2021 - 2028) 7.5%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Type
  • Equipment and Accessories
By Modality
  • Virtual Histology IVUS
  • iMap IVUS
  • Integrated Backscatter IVUS
By End User
  • Hospitals and Clinics
  • Diagnostic Centers
  • Academic and Research Institutes
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Koninklijke Philips N.V.
  • GE Healthcare
  • Siemens AG
  • Boston Scientific Corporation
  • Infraredx, Inc.
  • Terumo Corporation
  • Axle International
  • Conavi Medical Inc.
  • Canon Medical Systems
  • Abbott
  • ACIST Medical System

Intravascular Ultrasound (IVUS) Devices Market Players Density: Understanding Its Impact on Business Dynamics

The Intravascular Ultrasound (IVUS) Devices Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

intravascular-ultrasound-devices-market-cagr

Type-Based Insights

Based on type, the intravascular ultrasound (IVUS) devices market is segmented into equipment and accessories. In 2021, the accessories segment held a larger market share, and the same segment is estimated to register a higher CAGR of 7.7% in the market during the forecast period

End User-Based Insights

Based on end user, the intravascular ultrasound (IVUS) devices market is segmented into hospitals and clinics, diagnostic centers, and academic and research institutes. In 2021, hospitals and clinics segment held a larger market share. However, the diagnostic centers segment is estimated to register a higher CAGR of 7.9% during the forecast period

 

Companies commonly adopt inorganic strategies such as mergers and acquisitions to cater to changing customer demands and maintain their brand names worldwide. Players operating in the intravascular ultrasound (IVUS) devices market also adopt organic strategies, such as product launch and expansion, to outstretch their footprint and product portfolio worldwide and meet the growing demand.

By Type

  • Equipment
    • Catheters
    • Guidewires
    • Others
  • Accessories

By Modality

  • Virtual Histology IVUS
  • iMap IVUS
  • Integrated Backscatter IVUS

By End User

  • Hospitals and Clinics
  • Academic and Research Institutes
  • Diagnostic Centers

By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Africa
    • Rest of Middle East & Africa
  • South and Central America
    • Brazil
    • Argentina
    • Rest of South and Central America

Company Profiles

  • Koninklijke Philips N.V.
  • GE Healthcare
  • Siemens AG
  • Boston Scientific Corporation
  • Infraredx, Inc.
  • Terumo Corporation
  •  Axle International
  • Conavi Medical Inc.
  • Canon Medical Systems
  • Abbott
  • ACIST Medical System

Frequently Asked Questions

Koninklijke Philips N.V.; GE Healthcare; Siemens AG; Boston Scientific Corporation; Infraredx, INC.; Terumo Corporation; Axle International; Conavi Medical Inc.; Canon Medical Systems; Abbott, and ACIST Medical System are among the leading companies operating in the high throughput screening market.

The market is estimated to grow with a CAGR of 7.5% from 2021 to 2028.

Key factors such as the high prevalence of coronary artery diseases coupled with the increasing focus of numerous countries on building robust healthcare infrastructure will contribute to the expansion of the intravascular ultrasound devices market.

Intravascular Ultrasound (IVUS) is a catheter-based diagnostic technique used to diagnose and treat both arteries and veins. Ultrasound does not use or produce any ionizing radiation, has no known harmful effects, and can provide clear images of soft tissues that are not well seen on x-ray images.
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Comprehensive Market Sizing and Forecast Analysis
  • Detailed Segmentation Analysis
  • In-Depth Market Dynamics Assessment
  • Regional and Country-Level Insights
  • Competitive Landscape and Company Benchmarking
  • Strategic Business Intelligence

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA